chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided          No relevant concomitant medications were reported.  No treatment information was provided.
Rash also itches; Muscle pain; Rash on her left hand, left foot, right arm elbow and below stomach after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her left hand, left foot, right arm elbow and below stomach after 1st dose), RASH PRURITIC (Rash also itches) and MYALGIA (Muscle pain) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced RASH (Rash on her left hand, left foot, right arm elbow and below stomach after 1st dose). On an unknown date, the patient experienced RASH PRURITIC (Rash also itches) and MYALGIA (Muscle pain). The patient was treated with CORTISONE for Rash, at an unspecified dose and frequency and TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Rash on her left hand, left foot, right arm elbow and below stomach after 1st dose), RASH PRURITIC (Rash also itches) and MYALGIA (Muscle pain) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported. It was reported that the symptoms flared up if she stopped usage of the cream. Treatments also included Other skin creams.   This case was linked to MOD-2022-510173 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Mar-2022: Follow-up received updated No New information
reactive airway disease with multiple blood clots; reactive airway disease; After taking my shot I have deceased my need for inhaler; This is a spontaneous report from a contactable consumer (patient). This 64-year-old patient of unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included 2020 in the early stage of the Virus patient developed another blood clot and was hospitalized, reactive airway disease. Concomitant medications were not provided. The patient experienced reactive airway disease with multiple blood clots on unspecified date. The clinical course was reported as follows. He/she took the over 6 months ago. He/she also had reactive airway disease with multiple blood clots. 2020 in the early stage of the Virus he/she developed another blood clot and was hospitalized. After taking shot he/she had deceased his/her need for inhaler. The patient asked if think the shot affect more than the virus. Outcome of events was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Onset of symptom of neck and shoulder pain started approx 15-20 min after injection. Rated pain 1-2 out of 1-10. Pt stated pain radiated down spine. Pain was subsiding after 30 min.
Got the shot as soon:as it was available. I still got a light case of it/Suspected vaccination failure; Got the shot as soon:as it was available. I still got a light case of it; This case was reported by a consumer via media and described the occurrence of Suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (had at age of almost 3 years old). Concurrent medical conditions included allergic skin reaction.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group of patient was not reported however was captured as an adult as per vaccine indication. The patient got Shingles after vaccination. The patient had skin allergies hence he or she got shot as soon as it was avilable. The patient got light case of shingles in the fall of 2017. The patient's brother born with Chickenpox. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, laboratory confirmation, time to onset of shingles were unknown at the time of reporting.
headache, nausea, fatigue, left arm and shoulder sore, injection site still red and raised and warm
2 days after the injections fever/chills/body aches. 7 days after injection rash developed on right arm (site of shot). Called doctor, treated rash with OTC meds (CORTIZONE 10 lotions and ibuprofen), continued to worsen. 5/12/18 - rash worsened and became very painful. 5/15/19 - rash blistered. 5/16/18 - returned to doctor - diagnosed with shingles - started treatment.
nausea      diarrhea   fatigue     chills   prob. fever      headache    on and off for 5 days
pt recvd vax; pt devel fever; headache; chills, diarrhea, nausea; pt seen by MD & treated w/ iv fluids due to dehydration; pt lost 15 lbs;
Joint pain; Fever; can't walk for two days after; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "Joint pain"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "can't walk for two days after". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: She experienced some weird reactions: joint pain, fever, and can't walk for two days after, and for each of three consecutive doses she had the same reaction. The reporter had also an inquiry, and is asked if vaccines are FDA approved.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201160522 Same reporter/events/patient, different products; Report 4 of 4;
The patient is a 84 y.o. male with a history of CVA, CAD, Atrial fibrillation, Hypertension, Hyperlipidemia, Hypothyroidism, BPH, transferred from facility with COVID-19 pneumonia and found to have high O2 requirements requiring HHFNC. He completed 10 days of steroids, 5 days of remdesivir and CAP antibiotics while admitted. He was able to be weaned to safe levels of O2 for home discharge and was discharged home with home health on 12/4.    Acute hypoxic respiratory failure COVID-19 pneumonia Date of onset of symptoms: 11/12/2022 Symptoms present on admission: Cough, dyspnea, loss of taste Date of covid positive test: 11/19/2022 Vaccination status: vaccinated x3 (did not receive 2022 booster) Imaging: CTPA (11/19) diffuse scattered areas of groundglass opacities bilateral lungs, no PE Oxygen requirements on admission: HHFNC 60L Current oxygen requirements: 3L NC Medical therapy: remdesivir (done), ceftriaxone/azithromycin (done), dexamethasone (end 11/30) S/p IV lasix during admission -- > switched to lasix 40 PO daily -- will give for 10 days on discharge Special isolation ended: 11/30/2022 Home O2 eval 12/3 -- requires 3-5L NC continuously Will need to f/u with PCP and consider pulmonary referral if still requiring high levels of O2   Paroxysmal Atrial fibrillation NSR on admission Continue home metoprolol succinate 50mg daily Continue Eliquis   Essential hypertension Continue Toprol   Hyperlipidemia Continue simvastatin   Hypothyroidism Continue Synthroid   BPH Continue Flomax and finasteride
Information has been received from a 58 year old male consumer with a history of shingles two weeks before vaccination, high cholesterol, hypertension, heart attacks with stent placement in 2004 who on 30-OCT-2007 was vaccinated with a dose of ZOSTAVAX.  Concomitant therapy included VALTREX which was completed a week before vaccination, LIPITOR, and RESTORIL.  On 30-OCT-2007 the patient experienced a "bad, bad headache" for 2 days where he could not hold his head up after receiving vaccination with ZOSTAVAX.  The patient took Tylenol which did not help.  The headache resolved after 2 days.  The patient did not seek medical attention.  No product quality complaint was involved.  Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 21-SEP-2015, the patient was vaccinated with the improperly stored dose of (Merck) VARIVAX (lot number reported as L020000 and expiration date 02-JUN-2017) (dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effects were reported. Additional information has been requested.
RUDENESS, SWELLING, pain at injection site. Now is about 6 inches by 6 inches in rudeness and swelling. Hot to touch. Itchy. Using ice topically to reduce the itch.
patient fainted briefly after receiving the vaccine. i think she fainted from nerves. me and her mom sat with her for a few minutes and she recovered completely
arm soreness; cough; congestion in upper airway/upper chest; Fatigue; Nasal congestion; Runny nose; itchy nose; Lethargic; A spontaneous report was received from a nurse concerning herself, a 36 year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced sore arm, nasal congestion, runny nose, itchy nose, a little fatigue, cough, congestion in upper airway/upper chest and feeling a little lethargic.  The patient's medical history included an unspecified allergy. Products known to have been used by the patient, within two weeks prior to the event, included loratadine.    On 26 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number not provided) intramuscularly for prophylaxis of COVID-19 infection.   The patient reported that she felt fine the first two days after receiving the vaccine but experienced a sore arm at the end of day 3-4 that resolved. On the sixth day, the patient reports that she had nasal congestion, runny nose, itchy nose, and a little fatigue. She reported that on 01 Jan 2021 experienced an intermittent productive cough and nasal congestion was improving. The patient also reported some congestion in her upper airway/upper chest and feeling lethargic. Treatment for the event included loratadine which the patient states she was already taking for the weather change and allergies.    Action taken with mRNA-1273 in response to the events was not provided/unknown.   The outcome of the event, sore arm, was considered resolved on 29 Dec 2020. The outcome of the events, nasal congestion, runny nose, itchy nose, a little fatigue, cough, congestion in upper airway/upper chest, and feeling a little lethargic was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Chills, low grade fever, nausea, headache, dizziness, weakness, extreme fatigue for 36 hours.  Headache and dizziness continued for the next 12 hours.
ADULT OBSTRUCTIVE SLEEP APNEA ACUTE NON ST ELEVATION MI 2/7/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
8-10cm erythema with mild warmth, non-tender, minimal swelling.  Treatment with Benadryl, cold compress, Tylenol.
Myalgia, Fever, ErythemaMultiform, CHILLS,SWELLING AND PAIN AT INJECTION SITE
I waited 30 minutes after the vaccine. No issues and went back to work. At 70 minutes after shot administration, felt itchy on limbs, then trunk and neck, then ears, eyes and into scalp. Symptoms progressed over the next 2 hours (flushed neck and then lips felt tingly and numb). At 7:30 my soft palate started to feel numb and I started to have some difficulty swallowing. Went to ER. Symptoms continued. After IV meds given swallowing difficulty continued to worsen so I was given a low dose shot of Epi. Swallowing improved (not to normal but not as severe) over the next hour but itchiness returned. It is now 8:00pm on 1/9/2021 and I continue to have itchiness, my tongue and soft palate are still numb but I am able to swallow fairly well and my entire face has decreased sensation to touch.
red/The redness is prominent, and it is at the top of her arm. It began on day 16; mildly sore; Both itchiness and soreness are mild; she's had a rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red/The redness is prominent, and it is at the top of her arm. It began on day 16), PAIN (mildly sore), PRURITUS (Both itchiness and soreness are mild) and RASH (she's had a rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included CALCIUM for Supplementation therapy, ESCITALOPRAM OXALATE (LEXAPRO) and TRAZODONE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ERYTHEMA (red/The redness is prominent, and it is at the top of her arm. It began on day 16), PAIN (mildly sore), PRURITUS (Both itchiness and soreness are mild) and RASH (she's had a rash). At the time of the report, ERYTHEMA (red/The redness is prominent, and it is at the top of her arm. It began on day 16), PAIN (mildly sore), PRURITUS (Both itchiness and soreness are mild) and RASH (she's had a rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Non-significant FUP- Reporter contact info updated
Patient did not have an adverse event, but received Pfizer for the third/booster dose after he originally received 2 doses of Moderna. Patient did not have adverse event in the 15 minute monitoring period after receiving the vaccine, nor did he have any to report later in the day ~2 hours after administration.
Administered an expired vaccine to a patient. The vial had been moved to the refrigerator 71 days ago, and was incorrectly labeled.
p/vax pt arm soreness; 1wk later former bulls eye rash on leg begin to have pain;
3.5 hrs following administration I experienced a near syncopal episode followed by vomiting.
Fever 103, problems walking or could not lift her legs. Had never had vaccines before 8-11-11. On 8/12/2011 she was ambulating well with a mild limp.
pt went to clinic requesting pregnancy test-testing not done on that day, but pt was given vax that was past due & pt gave birth to male child profoundly deaf;
This spontaneous report as received from a healthcare worker refers to a 21 year old patient of unknown gender. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 20-AUG-2015 the patient was vaccinated with an improperly stored dose of GARDASIL 9 (Lot# L000610, expiration date 31-JAN-2017) (Strength, dose and route were not provided). Concomitant medication was not reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Mother called to report that child had red rash around injection site.  Concerned for child.  Explained the risks of the vaccine reaction to her.
PNEUMOCOCCAL SHOT WAS GIVEN ON LEFT ARM, SERVERE PAIN DURING THE NIGHT REQUIRING PAIN PILL. INJECTION SITE\AREA SLIGHTLY SWOLLEN AND WARM TO TOUCH. WAS SEEN BY DR. ON 11/09/2005 AND WAS GIVEN ANTIBIOTICS.
body aches; nausea; tiredness; This is a spontaneous report from a non-contactable consumer (patient). A 62-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 26May2021 as single dose. Historical vaccination included dose 1 of bnt162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported)on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reportedly, patient was asking if she is allowed to take her birth control pills regularly after getting her second vaccine dose. Patient reports that she got her second dose of the vaccine yesterday and wanted to make sure she could still take them. patient asking if body aches, nausea and tiredness are normal, how long the symptoms will last and what should I take for the symptoms. Patient reports that she received her second vaccine dose yesterday and reports having read the material from the Pfizer website about possible side effects but now asking if body aches, nausea and tiredness are normal, how long the symptoms will last and what should I take for the symptoms. On an unspecified date, the patient experienced body aches, nausea and tiredness. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
nausea, temperature (over 100), fatigue; all occurred almost 20-22 hours after vaccine; lasted for 18 hours
small cut; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2), administration date 12Mar2021 (Batch/Lot number: unknown) as DOSE 1, SINGLE for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: WOUND (non-serious), outcome "unknown", described as "small cut". Therapeutic measures were taken as a result of wound.  Additional Information: Caller was calling on behalf of husband who had a tetanus shot for a small cut last week. Her husband got first dose 12Mar2021. He got a TETANUS shot two weeks ago. He was scheduled to receive his second dose of the PFIZER COVID-19 vaccine on 03Apr2021 and wants to know if it was okay since he had the tetanus shot.  No follow-up attempts are possible. No further information is expected.
I had severe fatigue, joint pains, swelling, tinnitus, pressure in head, and nerve pain since January of this year. I went to the doctor about this. They did blood work, showed that I have lupus. They did a cardio stress test, showed that my cardiac is older that what I am.
She was lethargic at daycare and kept saying she was sick. She spiked a fever that night. We gave her MOTRIN and took her to the doctor the next day. They tested her for COVID-19, Flu, and Strep and she tested negative. We continued to give MOTRIN and she was better in a couple days.
tightness of chest; difficulty of breathing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)) (Batch/Lot number: unknown) as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHEST DISCOMFORT (non-serious), outcome "unknown", described as "tightness of chest"; DYSPNOEA (non-serious), outcome "unknown", described as "difficulty of breathing". Clinical course: The patient got a pneumococcal vaccine shot last 2001/2002 however she is unsure of the brand. She experienced difficulty of breathing and tightness of chest. The patient is concerned that she might experience the same side effects with the Pfizer BioNTech Covid-19 Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fast heart rate, Fatigue, Sweating, Chest Pain, Itching, Body Ache, Hives. Took Benadryl at 7:00am.
Started experiencing chest pains a couple days after I received my second dose. Ended up being hospitalized for almost 3 days. Now I am taking colchicine twice a day and ibuprofen as needed.
I have the stomach trouble; its been really bad stomach; its the reaction from the second booster; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Jul2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (FIRST BOOSTER, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: DIARRHOEA (non-serious) with onset Jul2022, outcome "unknown", described as "Diarrhea"; ABDOMINAL DISCOMFORT (non-serious) with onset Jul2022, outcome "unknown", described as "I have the stomach trouble; its been really bad stomach; its the reaction from the second booster".  Additional information: Reporter stated that had second booster last Friday and had stomach trouble ever since and talked to two nurses they thought its the reaction from the second booster. It had been a week tomorrow. Yes, because its been really bad stomach Saturday and then some diarrhea.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recvd vax & the next day exp swollen rt knee (edema) which was treated w/Relafen;